BNGO
$0.76
Revenue | $10.72Mn |
Net Profits | $-43.89Mn |
Net Profit Margins | -409.39% |
Bionano Genomics Inc’s revenue jumped 30.51% since last year same period to $10.72Mn in the Q4 2023. On a quarterly growth basis, Bionano Genomics Inc has generated 15.06% jump in its revenue since last 3-months.
Bionano Genomics Inc’s net profit fell -13.48% since last year same period to $-43.89Mn in the Q4 2023. On a quarterly growth basis, Bionano Genomics Inc has generated 61.01% jump in its net profits since last 3-months.
Bionano Genomics Inc’s net profit margin jumped 13.04% since last year same period to -409.39% in the Q4 2023. On a quarterly growth basis, Bionano Genomics Inc has generated 66.11% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.87 |
EPS Estimate Current Year | -0.87 |
Bionano Genomics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.87 - a 10.31% jump from last quarter’s estimates.
Bionano Genomics Inc’s earning per share (EPS) estimates for the current year stand at -0.87.
Earning Per Share (EPS) | -0.96 |
Return on Assets (ROA) | -0.33 |
Return on Equity (ROE) | -1.35 |
Bionano Genomics Inc’s earning per share (EPS) fell -637.92% since last year same period to -0.96 in the Q4 2023. This indicates that the Bionano Genomics Inc has generated -637.92% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bionano Genomics Inc’s return on assets (ROA) stands at -0.33.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bionano Genomics Inc’s return on equity (ROE) stands at -1.35.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-09 | -1.03 | -1.24 | -20.39% |
2023-11-08 | -0.97 | -1 | -3.09% |
2023-05-09 | -0.11 | -0.12 | -9.09% |
2024-03-05 | -0.87 | -0.96 | -10.26% |